Elevated TSH on Levothyroxine: Medication Adherence vs. Dose Adjustment
Your patient's elevated TSH (11.2 mIU/L) and low free T4 (0.75) on 88 mcg levothyroxine most likely indicates medication non-adherence rather than an inadequate dose, and you should assess compliance before increasing the dose.
Why Adherence is the Primary Suspect
The FDA labeling explicitly states that "persistent clinical and laboratory evidence of hypothyroidism despite an apparent adequate replacement dose of levothyroxine sodium may be evidence of inadequate absorption, poor compliance, drug interactions, or a combination of these factors" 1. Critically, the FDA recommends to "assess compliance, dose of medication administered, and method of administration prior to increasing the dose of levothyroxine sodium" 1.
The Clinical Picture Points to Non-Adherence
Both TSH and free T4 are abnormal together: The combination of markedly elevated TSH (11.2) with low free T4 (0.75) suggests the patient is receiving little to no thyroid hormone, not just an insufficient amount 1.
The dose is reasonable: 88 mcg is within the typical replacement range for most adults (full replacement is approximately 1.6 mcg/kg/day for younger adults, less for older adults) 1, 2.
Non-adherence is extremely common: Studies show that medication non-adherence is the most common cause of unsuppressed TSH levels in treated hypothyroidism, occurring in 16-20% of patients 3, 4, 5.
How to Assess Adherence Before Dose Changes
Step 1: Direct Assessment
- Ask specifically about missed doses, timing of medication, and whether the patient takes it on an empty stomach 6, 7.
- Verify pharmacy refill records—but recognize this alone doesn't confirm actual ingestion 6.
Step 2: Consider a Supervised Levothyroxine Absorption Test
If the patient denies non-adherence but labs remain abnormal:
- Administer a supervised oral levothyroxine bolus (typically weight-based, around 1000 mcg) and measure free T4 at baseline and 120 minutes 7.
- A normal rise in free T4 (approximately 54% increase from baseline) confirms absorption capacity and strongly suggests non-adherence 7.
- This test is "fast and inexpensive" and can be done in the outpatient setting 6.
Step 3: Trial of Weekly Supervised Dosing
- Once-weekly levothyroxine administration under supervision can be an effective alternative for non-compliant patients 3, 7.
- Studies show that weekly dosing with equivalent total weekly doses can normalize TSH in patients who failed daily therapy 3, 7.
When to Consider True Malabsorption or Dose Increase
Only after confirming adherence should you investigate other causes 1, 5:
Medications That Interfere with Absorption
- Proton pump inhibitors, calcium supplements, iron, bile acid sequestrants, soy products 5, 8.
- These account for approximately 21% of high-dose requirements 5.
Gastrointestinal Conditions
- Celiac disease: Check endomysial antibodies if absorption test is abnormal 5.
- Atrophic gastritis: Parietal cell antibodies are positive in 22% of patients requiring high doses 5.
- Helicobacter pylori infection 8.
True Dose Inadequacy
- If adherence is confirmed and absorption is normal, then increase the dose by 12.5-25 mcg increments 1.
- Recheck TSH in 6-8 weeks after any dose change 1.
Common Pitfalls to Avoid
Don't automatically increase the dose without assessing adherence first—this leads to unnecessary high doses and potential overtreatment once the patient does take medication consistently 1, 6.
Don't rely solely on patient self-report or pharmacy records as confirmation of adherence—these are unreliable 6.
Don't pursue extensive malabsorption workup (endoscopy, imaging) before confirming adherence—this increases costs and patient burden unnecessarily 3, 6.
Remember that levothyroxine has a narrow therapeutic index—overtreatment carries risks including cardiovascular effects and bone loss 1.